The Complete SPAC Guide: Formation to De-SPAC and Beyond

A SPAC is a shell company that goes public with one purpose: to find an operating company and merge with it. The structure inverts the traditional IPO. In a traditional IPO, an operating company sells shares to the public. In a SPAC, investors fund a blank check first and the company comes later. Everything else in this guide, the trust, the deadlines, the redemption rights, the vote, follows from that single inversion.

This guide walks the entire lifecycle in order, from formation through the first year of public-company reporting, so a sponsor or a target can see where their own decision sits in the sequence. It is written for both sides of the table. A sponsor planning a SPAC IPO will find the formation, IPO, and trust sections are about them. A private company fielding a SPAC merger will find the search, S-4, and post-close sections are about them. The deep dives linked throughout carry the detail on each stage.

The SPAC Lifecycle at a Glance

The lifecycle runs through eight stages: formation, the IPO, the trust period, the search and LOI, announcement and the S-4, the vote and closing, the Super 8-K, and post-close compliance. The table maps the sequence and the timing each stage typically takes.

Stage	What Happens	Typical Timing
1. Formation	Sponsor team forms the shell, funds founder shares, drafts the charter and governing documents.	4 to 8 weeks
2. SPAC IPO	Form S-1 filed, SEC review, unit pricing, exchange listing. Proceeds go to the trust.	3 to 5 months
3. Trust period	Proceeds sit in trust while the sponsor searches for targets. The shell files its own periodic reports.	Months 0 to 18-24
4. Search, LOI, financing	Sponsor evaluates targets, signs a letter of intent, and lines up PIPE or forward financing.	2 to 4 months
5. Announcement and S-4	Deal announced, Form 8-K filed, Form S-4 registered and cleared through SEC review.	3 to 6 months
6. Vote and closing	Shareholders vote, redemptions settle, the merger closes.	2 to 4 weeks
7. Super 8-K	Form 8-K with the target's business and audited financials filed within 4 business days of closing.	Days 1 to 4 after close
8. Post-close reporting	Forms 10-Q, 10-K, 8-K, Section 16 reports, and S-8 registrations as a new public company.	Ongoing

Timing varies with SEC review pace, financing complexity, and the target's audit readiness. The ranges above are observed practice, not rules.

End to end, a full cycle from formation to the first post-close 10-K commonly runs three to four years: formation and IPO inside a year, the search and deal inside the deadline window, the S-4 and vote across several months, and the first annual report a year after closing. Sponsors and targets who plan only to the closing miss most of the calendar.

Who Is Around the Table

SPAC deals involve more parties than a two-company merger, and each has its own economics.

• The sponsor. The team that forms the shell, funds the founder shares, and runs the search. The sponsor's return is the promote: founder shares purchased for nearly nothing that become roughly 20 percent of the combined company if a deal closes.
• The public shareholders. The IPO investors. They hold units, vote on the combination, and keep the redemption right the whole way. Their downside is capped near the trust value; that cap is why arbitrage funds dominate the register.
• The target. The private operating company the SPAC merges with. It negotiates valuation, financing, and lockups, and it inherits the reporting calendar on closing.
• The PIPE investors. Institutions that subscribe for shares at closing to fill the redemption hole. They negotiate registration rights and sometimes board seats.
• The underwriters. The banks that take the SPAC public, with a portion of their fee deferred until a combination closes.
• The trustee. The bank or trust company that holds the trust account and processes redemptions.

Every one of these parties signs something. The sponsor signs the underwriting agreement and later the merger agreement. The public shareholders cast votes and redemption elections. The target signs the merger agreement and the PIPE subscriptions. The paper trail is the lifecycle.

1. SPAC Formation

Before a SPAC exists as a public company, it exists as a shell formed by a sponsor, most often a Delaware corporation. The sponsor contributes nominal consideration for founder shares, drafts the charter and bylaws that will govern the entity, and installs the initial directors and officers. None of this is public yet. It is corporate formation work, but the decisions made here, how many founder shares, what redemption rights, which deadline, shape every later stage of the lifecycle.

The structure at formation is usually a two-class one. Class A shares are the public shares sold in the IPO. Class B shares are the founder shares, held by the sponsor, voting as a class on the charter amendments that extend the deadline or change the redemption mechanics. Class B shares typically convert to Class A one-for-one at the combination, and they often forfeit some or all of their balance if no deal closes, which is the sponsor's downside exposure. Founder shares equal to roughly 20 percent of the post-IPO equity is the market convention, purchased for a price near nothing. That 20 percent, the promote, is the economic engine of the structure and the single largest line in the dilution table the IPO prospectus must present.

The sponsor also typically buys private placement warrants at formation, sized to fund the shell's working capital for its whole life, because the trust is off limits for operating expenses. Working capital has real costs: audit fees, exchange listing fees, directors and officers insurance, transfer agent fees, and the legal fees that start accruing the day the S-1 is drafted. Sponsors who underfund the working capital raise end up funding the shell's expenses out of pocket, which is one of the quiet ways a SPAC search fails before it starts.

The sponsor team matters as much as the paperwork. Underwriters and the SEC will examine the sponsors' backgrounds, their prior SPAC experience, and any conflicts they carry into the search, and so will plaintiffs' lawyers if the deal later draws litigation. Directors and officers liability insurance for a pre-deal shell is its own negotiation, because the underwriters require it, the shell has no operating history to underwrite, and the tail coverage that survives the combination is priced accordingly.

Two formation decisions deserve the most attention because they are the hardest to change later. The first is the deadline, usually 18 or 24 months, which sets the search clock the rest of the lifecycle must beat. The second is the structure of the trust, which sets both the deal's funding source and the investors' exit. A sponsor who picks a longer deadline to buy search flexibility should understand that extensions still require a shareholder vote, often with a sweetener contributed to the trust, and shareholders have grown less generous with them. Charter amendments at this stage are cheap; the same amendments after the IPO require the Class B vote plus, in many deals, the public shareholders' approval.

2. The SPAC IPO

A SPAC IPO does not sell a company. It sells a shell: a publicly traded entity with no operations, no revenue, and one job, which is to raise a pool of cash in a trust and find an operating company to combine with. The offering mechanics overlap with a traditional IPO: a registration statement is filed on Form S-1, the SEC reviews it, an exchange listing is obtained, and the units are priced and marketed. The difference is the company. A traditional IPO registers an operating business. A SPAC IPO registers a search.

Units are the product. A unit typically pairs one common share with a fraction of a warrant, commonly one-half or one-third, and the fraction varies deal by deal. Warrants give the holder the right to purchase additional shares in the future, usually at a premium to the IPO price, often $11.50 or $12.00 against a $10.00 unit, and they become exercisable after conditions tied to the business combination are met. Whole warrants, halves, and thirds have all been used; the package is a pricing decision as much as a legal one. The exact terms, the fraction, the exercise price, the redemption call the SPAC usually holds, the exercise window, are set in the SPAC's formation documents and its IPO prospectus.

The underwriting agreement carries its own mechanics. Underwriting discounts are commonly split: a portion, often 2 percent, paid at the IPO, and the larger portion, often 3.5 percent, deferred and held until a combination closes. If the SPAC liquidates, the deferred piece is forfeited, so the underwriter's payday depends on the SPAC actually finding a target. That alignment is also a conflict, and the prospectus discloses it as one.

Because the SPAC is a shell, the S-1 draws specific SEC review attention. The dilution table, which shows public investors what their ownership becomes after the promote, the working capital warrants, and any forward purchase arrangements, gets close reading. The conflicts section, sponsor economics, finder's fees, potential target relationships, gets a full paragraph-by-paragraph review. Sponsors should expect comments on dilution and conflicts in the first round and should not treat either as a negotiation the SEC will drop.

The exchange listing standards for SPACs are their own checklist. Nasdaq and NYSE American each maintain blank-check listing rules covering the minimum public float, the number of public shareholders, round-lot holders, and the minimum offer price. A SPAC that cannot satisfy the shell-specific standards at the IPO does not list, regardless of how the offering goes.

The offering process itself usually moves faster than a traditional IPO because the company is simple. SEC review of a shell's S-1 is shorter than review of an operating company's registration statement, though it is not perfunctory, and the roadshow markets the sponsor team and the search strategy rather than financial performance, because there is none to present. Testing-the-waters meetings with qualified institutional buyers, available to emerging growth companies under the securities laws, let the sponsor gauge demand for the units before pricing. The IPO prices, the units list, the proceeds move into the trust, and the search clock starts on the IPO date.

For the stage-by-stage detail, including what the units contain and what happens if no deal closes, see the deep dive: How a SPAC IPO Works: From Blank Check to Public Shell.

3. The Trust Period

The funds raised through the IPO go into a trust or escrow account, where they remain until the time of a potential business combination. The trust is the deal's funding source, and it is also the investors' exit. Because shareholders have the right to redeem their public shares for a proportional share of the trust, the money is never entirely committed until the combination closes.

That is the structural point sponsors and targets should both understand before the IPO prices: the capital is real, but it is not loyal. Any shareholder can leave at the vote, and the trust balance shrinks accordingly. A SPAC that raises $150 million can arrive at the closing table with a fraction of that, which is why the financing plan, PIPEs, forward purchase agreements, minimum-cash conditions, gets built before the S-4 is filed, not after the vote is announced.

The trust's investment rules are narrow by design. Trust funds typically sit in US government securities or money market funds holding them, with the investment restrictions written into the trust agreement, because the investors' redemption right depends on the money being there. Interest earned becomes part of the redeemable balance; taxes on that interest, where the trust is not pass-through, are a real accounting line, and the S-1 discloses the expected redemption value per share including it.

The trust period is not quiet on the compliance side either. The SPAC is a public company from the IPO forward, even with no operations. It files its own Forms 10-Q and 10-K as a shell, maintains its exchange listing under the continued-listing rules that apply to blank-check companies, and keeps its officers and directors inside the Section 16 reporting regime. The shell's accounting has its own edges: the warrants and the redeemable Class A shares require classification decisions, and after 2021, when dozens of SPACs restated their warrant accounting following SEC guidance that certain warrants should have been classified as liabilities rather than equity, those decisions get close scrutiny from auditors and the SEC. A sponsor should retain an auditor comfortable with shell-company accounting from day one, not one who treats the shell's 10-K as an ordinary small-company filing.

The deadline runs through all of it. SPACs typically have 18 to 24 months from the IPO to complete a business combination. If no deal closes inside the window, the SPAC must return the funds to investors or request an extension from its shareholders. Extensions are their own mini-deal: a proxy or information statement, a vote, and commonly a contribution from the sponsor into the trust, a few cents per share, to buy the extra months. Extensions buy time, but they do not change the underlying math: a shell that cannot find a target dissolves and returns the trust, and the sponsor absorbs the formation costs.

4. The Search, the LOI, and the Financing Plan

With the SPAC public and its proceeds in trust, the sponsor hunts for an operating company. Some SPACs are formed with a specific sector in mind, energy, healthcare, technology, financial services, and search within it. Others cast widely. Either way, the first real deal document is the letter of intent, and its terms deserve more attention than SPAC parties tend to give them, because the LOI sets exclusivity, valuation, and the timeline to definitive documents while diligence runs.

The LOI should record the parties' shared understanding on price, the stock and cash consideration mix, the exclusivity window, and the conditions each side needs before signing definitive documents. Exclusivity is the term that bites: it stops the target from shopping the deal while the SPAC's clock runs, and a target that signs a long exclusivity period against a short SPAC deadline has traded away its leverage for the SPAC's problem. For guidance on the terms that move a deal at LOI stage, see our note on letters of intent in M&A.

Valuation in a de-SPAC is a negotiated enterprise value, not a marketed price. The SPAC and the target agree on what the combined company is worth, the trust cash and any PIPE are counted against it, and the target's shareholders receive shares of the combined company in the balance. The negotiation is really three negotiations at once: enterprise value, the cash component, and the dilution each side absorbs from the promote, the warrants, and any earnout. Targets should model the post-closing capitalization table themselves rather than accept the sponsor's version, because the share count the target's holders actually receive is where the deal's real price lives.

The financing plan covers the redemption hole. PIPE subscriptions, commitments from institutional investors to buy shares at a fixed price at closing, are the standard tool, negotiated in parallel with valuation because the PIPE price and the enterprise value are two halves of the same math. Forward purchase agreements, where the sponsor or its affiliates commit to buy shares at closing, play the same role without the marketing effort a PIPE requires. Non-redemption agreements, side deals paying public shareholders to hold rather than redeem, have drawn SEC scrutiny and should be handled with care. A target should insist on seeing the whole financing plan, and the minimum-cash condition that protects it, before signing exclusivity, not after.

A target signing a SPAC LOI should also test the sponsor's ability to close. A SPAC near its deadline with a thin trust, no PIPE, and a history of failed votes is not a buyer; it is a calendar risk. Diligence runs both directions in a de-SPAC, and the target's board owes its shareholders an assessment of the counterparty, not just of the price.

5. Announcement and the Form S-4

Once definitive documents are signed, the de-SPAC is announced. The announcement triggers a run of filings: a Form 8-K reporting the merger agreement within four business days, the investor presentation, and the Form S-4 registration statement that will carry the proxy statement and prospectus to the SPAC's shareholders and the target's security holders. The S-4 for a de-SPAC is a hybrid document, part proxy, part prospectus, and it is the single largest drafting project in the lifecycle.

The announcement also produces its own disclosure stream. The investor presentation that explains the deal to the public is filed under the rules that govern communications about registered business combinations, and every deck and call transcript lands in the SEC's EDGAR record. Statements made at announcement get scrutinized later, in litigation and in the SEC's review of the S-4, so the presentation is drafted with the same care as the filing itself. Projections in the deck are subject to the SEC's SPAC-specific requirements, and both the sponsor and the target answer for what the deck claims.

The S-4 goes through SEC review, and the review commonly runs several months. Comments focus on the projections, the dilution, the conflicts, and the target's financial statements, which must be audited to public-company standards and presented for the periods the form requires. The SEC's SPAC rules, adopted in 2024, added requirements to this material: disclosures about the projections and the co-investment interests in the deal, and a due diligence framework for the underwriters. Both sides should budget serious time for comment rounds, because the S-4 clock sits inside the deadline clock, and a target with audit problems burns both.

The target's own readiness drives the S-4 calendar as much as the drafting does. A private company should arrive at a de-SPAC with its public-company reporting largely in order: PCAOB-audited financial statements for the required periods, a reporting team that can produce Forms 10-Q and 10-K on schedule after closing, governance documents ready for exchange-listing standards, and internal controls work started rather than deferred. Companies that postpone this work until after signing discover that the S-4 comment period is an expensive place to build it.

6. The Vote, Redemptions, and Closing

After the S-4 is effective, the proxy is mailed and the vote is scheduled. Public shareholders vote on the combination and the related proposals, the charter amendments, the equity incentive plan, the director elections. Redemption rights mean the vote is also an exit: any public shareholder can redeem shares for a proportional share of the trust rather than stay in the deal. High redemptions shrink the cash at closing, and a deal can fail its minimum-cash condition even after winning the vote.

Sponsors mitigate redemption risk with PIPEs, forward purchase agreements, and backstops. Targets should ask for the mitigation plan in writing before the vote, because after the vote it is too late to renegotiate the financing. For the stage-by-stage sequence from announcement through closing, see the deep dive: The De-SPAC Process Step by Step: From Target Search to Super 8-K.

The redemption mechanics deserve their own paragraph, because they decide the deal's cash. A public shareholder who redeems receives a pro-rata share of the trust, principal plus a portion of the interest earned, and the redemption price is set by the trust agreement, commonly $10.00 per share plus accrued income. Redemption is the shareholder's right, not the board's, and the election deadline is set by the proxy rules: written notice to the SPAC, typically delivered up to two business days before the vote, with the shares held in book entry at the transfer agent or in a broker account that can execute the election. Shareholders who do nothing stay in the deal by default. The practical consequence is that redemptions arrive late, in a rush, and unpredictably, which is why the minimum-cash condition exists to protect the target and why PIPE terms are sometimes re-cut between the vote and the closing.

Closing mechanics carry the usual M&A issues, consideration structure, escrows, holdbacks, and earnouts, with one addition specific to this structure. Earnouts in de-SPACs are common and commonly disputed, because the share-price triggers depend on trading volume and market sentiment, not just performance. A target should model whether the trigger prices are achievable under conservative volume assumptions before accepting an earnout as part of its consideration.

Lockups surround the closing. Sponsor shares and founder warrants are typically locked up for a period after the combination, and target shareholders who receive shares in the merger are commonly locked up too, with a portion released on a schedule tied to share-price milestones or time elapsed. Lockups are negotiated, not standardized, and they interact with the earnout triggers: a tight lockup can hold the very float that a share-price trigger needs to be achievable. Targets should read the lockup and the earnout as one system, not two terms.

7. The Super 8-K

Within four business days of closing, the combined company must file a Form 8-K that includes the target's business description and audited financial statements, the same information that would have appeared in a Form 10 registration statement had the target gone public on its own. Practitioners call it the Super 8-K. It puts the target's full operating history into the public record in one filing, and it is the document the market reads as the de-SPAC's birth certificate.

The Super 8-K is also where the combined company's disclosure obligations begin in earnest. The financial statements must satisfy the form's requirements, the narrative must describe the business the public company now is, and any material agreements from the transaction, the merger agreement, the PIPE subscriptions, the registration rights, are filed as exhibits. Drafting starts well before closing, in parallel with the S-4, so the four-business-day window is a filing deadline rather than a drafting deadline.

8. Post-Close Compliance: The First Year as a Public Company

The vote and the closing are not the end of the lifecycle. The combined company now owes the full public-company calendar: quarterly Forms 10-Q, the annual Form 10-K with PCAOB-audited financials, current Forms 8-K, Section 16 reports for insiders, and proxy materials for the next annual meeting. The first 10-K is the hardest, because internal controls over financial reporting must be evaluated in the first annual report, and the target inherits a reporting maturity it may never have needed as a private company.

The first-year calendar is worth laying out, because a new public company is often surprised by how quickly it arrives. The first 10-Q is due roughly 45 days after the first quarter-end the combined company reports as a public company. The first 10-K is due 90 days after fiscal year end for most filers. Section 16 Forms 3 for the new insiders are due within 10 days of the closing, and every subsequent reportable transaction on Form 4 is due within two business days. Any material agreement, earnings release, or non-reliance event triggers an 8-K inside four business days. And the year-one internal controls evaluation for the first 10-K means the company needs its documentation and testing program running during the year, not assembled the month before the report is filed.

Governance arrives with the listing too. Exchange-listed companies need boards that satisfy the independence and committee requirements: an audit committee with a financially literate chair, compensation and nominating committees, and codes of conduct adopted and disclosed. Many private companies have none of this on closing day. The de-SPAC timeline builds these into the S-4 and the closing checklist, because the exchange will not let the combined company trade without them.

Two post-close items deserve early attention. First, resale registration: shares issued in the de-SPAC, to the target's legacy shareholders and to PIPE investors, often need a resale registration statement before they can trade freely, and registration-rights agreements negotiated at signing set the deadlines for it. See our guide on resale registration statements. Second, insider reporting: the de-SPAC creates a new set of Section 16 insiders at the combined company, and the first Forms 3 are due within 10 days of becoming an officer, director, or 10 percent holder. See our guide on Section 16 and Forms 3, 4, and 5.

The combined company is also a former shell, and that status follows the stock. Securities issued by a shell company, and securities acquired from the shell in the combination, generally cannot be resold under Rule 144's holding-period safe harbor until the company has ceased to be a shell for twelve months, filed the Form 10-type information with the SEC, and satisfied the other conditions that apply to former shells. The practical effect is that some shares that investors expected to be liquid on closing are restricted for an additional period, and the closing table needs to reflect that honestly. See our guide on Rule 144 legal opinions and restricted stock for how former-shell status is handled in practice.

The new reporting calendar is a standing obligation, and the penalties for missing it are real. Our flat-fee SEC compliance counsel exists for exactly this first year, and companies that enter it with a reporting team already in place spend far less on remediation than companies that assemble one after the first delinquency notice.

Litigation exposure is part of the deal's price. Because the S-4 is a Securities Act registration statement, the target's directors and officers, its auditors, and the deal's other signers face Section 11 exposure on the S-4's disclosures, and claims under Section 10(b) and Rule 10b-5 commonly follow a post-closing stock decline. The projections, the conflicts, and the earnout disclosures are the usual battlegrounds. D&O insurance negotiated at formation, with tail coverage that survives the combination, is the standard mitigation, and its cost belongs in any honest view of what a SPAC costs.

Where SPAC Deals Go Wrong

Most de-SPAC failures are not exotic. They come from a handful of recurring patterns, and both sponsors and targets can see them coming.

• Liquidation. The deadline arrives with no deal. The trust is returned, the sponsor loses its formation costs, and the target that spent months in exclusivity has burned its market window.
• The failed vote. Shareholders vote the deal down, or redemptions gut the trust below the minimum-cash condition. A deal that wins approval but loses its financing is a failed deal with extra steps.
• Audit surprise. The target's financial statements cannot be brought to PCAOB and S-4 standards inside the deadline. Audit problems discovered during SEC review are the most common cause of blown de-SPAC timetables.
• Stale trust economics. A SPAC that trades below trust value for months attracts redemption by default, because arbitrage holds redeem rather than roll. Sponsors who ignore the register's composition plan for a trust that will not be there.
• Disclosure litigation. The projections in the investor deck and the S-4 become the complaint. The exposure is manageable when the record supports the numbers.
• Post-close delinquency. The combined company misses its first filings, the exchange issues deficiency notices, and the listing the whole structure existed to obtain is at risk. See our guides on SEC reporting delinquencies and Nasdaq deficiency notices.

What a SPAC Costs

The SPAC route is not cheap, and its costs are not concentrated in one place. Beyond the legal and accounting fees any public transaction carries, the structure has embedded costs that do not exist in a traditional IPO. The table lists the main lines and where they fall.

Cost Line	What Drives It	Where It Lands
Sponsor promote	Founder shares, typically about 20 percent of post-combination equity, purchased for a nominal price at formation.	Dilution borne by post-close shareholders
Underwriting discount	Commonly split: a portion paid at the IPO, the larger portion deferred and paid from trust or PIPE proceeds at closing.	Trust and PIPE proceeds at closing
Working capital warrants	Private placement warrants the sponsor buys to fund the shell's operations, since trust funds cannot pay expenses.	Sponsor at formation
Redemption risk	Public shareholders redeem at the vote, shrinking the cash the target receives.	Target's balance sheet at closing
De-SPAC transaction costs	S-4 drafting and SEC review, PCAOB audit of the target, financial advisor fees, printer and miscellaneous.	Deal costs at closing
Post-close compliance	10-Q and 10-K reporting, internal controls evaluation, Section 16 reporting, transfer agent and exchange fees.	Combined company, ongoing

For a comparison of what the traditional IPO path costs against these lines, see SPAC vs. Traditional IPO: Speed, Price, and What Each Path Costs.

SPAC vs. Reverse Merger

A reverse merger and a de-SPAC both take a private company public by merging it into an entity that is already public. The differences are the money and the process. A reverse merger with a trading shell can close in weeks, costs a fraction of what a SPAC transaction costs, and raises no new capital: the company gets the listing and the reporting obligations, and separately arranges any financing, often a PIPE after closing. A de-SPAC brings cash in the trust, an underwritten SEC-reviewed process, an exchange listing at the NASDAQ or NYSE American level, and costs that reflect all three.

When does each fit? A de-SPAC suits a company that wants public-market cash at closing, can support the audit and disclosure burden of an S-4, and can live with the promote economics. A reverse merger suits a company that wants public status for its own reasons, follow-on financing, liquidity for legacy holders, acquisition currency, and does not need the trust cash at closing. Many companies evaluate both against a straight IPO; see our comparisons of IPO vs. reverse merger and SPAC vs. traditional IPO for the side-by-side detail.

Where to Go Deeper

Each stage of the lifecycle has a dedicated deep dive on this site:

• How a SPAC IPO Works: From Blank Check to Public Shell covers the IPO stage, the units, the trust, and the liquidation deadline.
• The De-SPAC Process Step by Step: From Target Search to Super 8-K covers the announcement-to-closing sequence in order.
• SPAC vs. Traditional IPO: Speed, Price, and What Each Path Costs compares the two paths to public markets side by side.

Related guides on adjacent parts of the process: IPO vs. Reverse Merger, Proxy and Information Statements, and SPAC and De-SPAC Services for the firm's service offering in this area.